Lectin Drug Conjugates Targeting High Mannose N-Glycans.

ABSTRACT: Cancer-associated alterations to glycosylation have been shown to aid cancer development and progression. An increased abundance of high mannose N-glycans has been observed in several cancers. Here, we describe the preparation of lectin drug conjugates (LDCs) that permit toxin delivery to cancer cells presenting high mannose N-glycans. Additionally, we demonstrate that cancer cells presenting low levels of high mannose N-glycans can be rendered sensitive to the LDCs by co-treatment with a type I mannosidase inhibitor. Our findings establish that an increased abundance of high mannose N-glycans in the glycocalyx of cancer cells can be leveraged to enable toxin delivery.

SUBMITTER: Kurhade SE 

PROVIDER: S-EPMC9738879 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature